Clinical Practice Guideline, Issues 5-6U.S. Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research, 1993 |
From inside the book
Results 1-5 of 58
Page 4
... initial treatment target . If the nonmood disorder is generalized anxiety or personality disorder , the major depressive disorder is the first treatment target , because patients with one of these two nonmood conditions are not ...
... initial treatment target . If the nonmood disorder is generalized anxiety or personality disorder , the major depressive disorder is the first treatment target , because patients with one of these two nonmood conditions are not ...
Page 19
... INITIAL TREATMENT OBJECTIVE : Substance abuse ' Change medications General medical disorder ' Causal , nonmood psychiatric disorder Grief reaction MOOD DISORDER PERSISTS ? Yes TREAT MOOD DISORDER ' Depending on the clinical situation ...
... INITIAL TREATMENT OBJECTIVE : Substance abuse ' Change medications General medical disorder ' Causal , nonmood psychiatric disorder Grief reaction MOOD DISORDER PERSISTS ? Yes TREAT MOOD DISORDER ' Depending on the clinical situation ...
Page 22
... initial evaluation are more likely to have major depressive disorder 1 year later . Men , but not women , with both dysthymic and major depressive disorders initially are more likely to have major depressive disorder 1 year later . For ...
... initial evaluation are more likely to have major depressive disorder 1 year later . Men , but not women , with both dysthymic and major depressive disorders initially are more likely to have major depressive disorder 1 year later . For ...
Page 36
... initial manic episodes , while women are more likely to experience initial depressive episodes . The mean duration of untreated manic episodes is 6 months ; the mean duration of untreated major depressive episodes is approximately 8 to ...
... initial manic episodes , while women are more likely to experience initial depressive episodes . The mean duration of untreated manic episodes is 6 months ; the mean duration of untreated major depressive episodes is approximately 8 to ...
Page 43
... initial treatment target . ( Strength of Evidence = A. ) □ If the nonmood disorder is generalized anxiety or personality disorder , the major depressive disorder is the first treatment target , because patients with either of these two ...
... initial treatment target . ( Strength of Evidence = A. ) □ If the nonmood disorder is generalized anxiety or personality disorder , the major depressive disorder is the first treatment target , because patients with either of these two ...
Contents
19 | |
20 | |
23 | |
35 | |
43 | |
105 | |
127 | |
147 | |
32 | |
35 | |
41 | |
43 | |
55 | |
67 | |
73 | |
79 | |
85 | |
99 | |
105 | |
119 | |
xiv | |
1 | |
2 | |
7 | |
167 | |
173 | |
1 | |
5 | |
7 | |
14 | |
18 | |
21 | |
34 | |
48 | |
55 | |
57 | |
61 | |
67 | |
77 | |
95 | |
Other editions - View all
Common terms and phrases
acute phase treatment acute treatment affective disorder AHCPR alcoholism amitriptyline antidepressant medications Arch Gen Psychiatry associated bipolar disorder chronic Clin cognitive therapy combined treatment criteria Department of Psychiatry depressed patients Depression Guideline Panel depressive symptoms diabetes diagnosis dosage drug dysthymic disorder efficacy Electroconvulsive therapy episodes of major evaluation family history fluoxetine followup hemoglobin hemoglobinopathy imipramine infants interpersonal psychotherapy Kupfer laboratory major depressive disorder major depressive episode MAOIS marital medical conditions medical disorders Medicine Mental Health meta-analysis mood disorder N/A N/A N/A NIMH nonmood outcome outpatients patients with major percent personality disorder placebo population practitioner prevalence primary care settings psychiatric disorders Psychiatry psychosocial psychotic randomized controlled trials recurrent reported Research samples screening program sickle cell anemia sickle cell disease sickle cell trait side effects somatic specific Strength of Evidence studies suicide syndrome tests trazodone treatment of depression treatment of major tricyclic University weeks Weissman
Popular passages
Page 96 - Endicott J, Spitzer RL: A diagnostic interview: the Schedule for Affective Disorders and Schizophrenia.
Page 44 - JI, Woods G, et al. Prophylaxis with oral penicillin in children with sickle cell anemia.
Page 40 - Presence, while depressed, of two (or more) of the following: ( 1 ) poor appetite or overeating (2) insomnia or hypersomnia (3) low energy or fatigue (4) low self-esteem (5) poor concentration or difficulty making decisions (6) feelings of hopelessness C.
Page 26 - Markedly diminished interest or pleasure in all, or almost all, activities most of the day, nearly every day (as indicated by either subjective account or observation made by others...
Page 128 - Guidelines are systematically developed statements to assist practitioner and patient decisions about appropriate health care for specific clinical conditions.
Page 142 - ... drugs. References: 1. Mendels J, Amin MM, Chouinard G, et al. A comparative study of bupropion and amitriptyline in depressed outpatients. J Clin Psychiatry. 1983;44(5. sec 2):1 18-120.
Page 161 - ... depressive disorders in the medically ill, on endocrine changes in patients with primary depression, and on pharmacokinetic drug interactions. His research has contributed to the understanding of depression in the medically ill, as well as the potential relationship of hypothalamic-pituitary-adrenal axis dysfunction in patients with primary affective disorder. Dr. Kathol has lectured widely, is on the editorial board of several journals, holds membership on the boards of national organizations,...
Page 101 - Paffenbarger RS, McCabe LJ. The effect of obstetric and perinatal events on risk of mental illness in women of childbearing age.
Page 124 - President Association for Clinical Psychosocial Research Don R. Lipsitt, MD President, American Association of General Hospital...
Page 21 - ... inference, available data, and panel consensus. When the evidence is reasonably clear, though modest in amount, these findings are noted, and a tentative recommendation is offered. Thus, the guidelines that follow are coded according to the strength of the available evidence as interpreted by the panel: A Good research-based evidence, with some panel opinion, to support the guideline statement. B Fair research-based evidence, with substantial panel opinion, to support the guideline statement....